FDA fills top attorney post
This article was originally published in The Rose Sheet
Executive Summary
Former Department of Justice attorney Sheldon Bradshaw will serve as the new FDA Chief Counsel, effective April 18. The agency announced Bradshaw would replace Dan Troy, who joined Sidley Austin Brown & Wood in January, on April 4. Bradshaw has worked at the DoJ Civil Rights Division, where he was the Principal Deputy Assistant Attorney General. Before that, he was Deputy Assistant Attorney General in the DoJ Office of Legal Counsel. Gerald Masoudi, who joined FDA's Office of Chief Counsel as Deputy Chief Counsel in November, has temporarily filled the position since Troy's resignation (1"The Rose Sheet" Nov. 22, 2004, p. 8). Masoudi said he will remain at the office, returning to his post as deputy to Bradshaw...
You may also be interested in...
Deputy Chief Counsel Masoudi Will Succeed Troy In Acting Capacity
Gerald Masoudi will be FDA's acting chief counsel after Daniel Troy departs Nov. 24
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.